Gm. Ward et al., Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: A new approach to the insulin compartment, METABOLISM, 50(5), 2001, pp. 512-519
The minimal model of Bergman et al has been used to yield estimates of insu
lin sensitivity (Si) and glucose effectiveness (Sg) in type 2 diabetes by i
ncorporating exogenous insulin protocols into the regular intravenous gluco
se tolerance test (IVGTT). These estimates, however, are influenced by the
degree to which the dose of exogenous insulin is greater than the physiolog
ic response to a glucose load. Moreover, most studies have related to type
2 diabetes subjects whose diabetes was relatively mild in terms of therapeu
tic requirements. To develop a "minimal disturbance" approach in estimating
Si and Sg in type 2 diabetes, we have used a reduced glucose load (200 mg/
kg) and a "physiologic" insulin infusion throughout the IVGTT in a series o
f 8 patients, 5 of whom were insulin-requiring. Data from this approach wer
e analyzed using the modelling program CONSAM to apply the Bergman model, e
ither unmodified (BMM), or incorporating an additional delay element betwee
n the plasma and "remote" insulin compartments (MMD). Application of the MM
D and extension of the IVGTT from 3 to 5 hours improved successful resoluti
on of Si and Sg from 37.5% (BMM, 3-hour IVGTT) to 100% (MMD, 5-hour IVGTT).
Si was reduced in these type 2 diabetes patients compared with normal subj
ects (1.86 +/- 0.60 v 8.65 +/- 2.27 min(-1) . muU(-1) . mL x 10(4) P < .01)
. The results were validated in the type 2 diabetes group using a 2-stage e
uglycemic clamp ((Si)CLAMP = 2.02 +/- 0.42 min(-1) . <mu>U-1 . mL x 10(4) P
> .4). Sg was not significantly reduced (2.00 +/- 0.25 type 2 diabetes v 1
.55 +/- 0.26 normal min(-1) x 10(2)). Data from a group of normal nondiabet
ic subjects was then analyzed using the MMD, but this approach did not enha
nce the fit of the model compared with the BMM. This result indicates that
the delay in insulin action in type 2 diabetes represents an abnormality wh
ereby the onset of insulin action cannot be described as a single phase in
the transfer of insulin from plasma to the remote compartment. It is postul
ated that the physiologic basis for this delayed action may relate to trans
capillary endothelial transfer of insulin, this process limiting the rate o
f onset of insulin action. Copyright (C) 2001 by W.B. Saunders Company.